INDEX 851
trichoepithelioma, 674, 675, 678, 689
trichofolliculoma, 675, 677, 678, 691
trichograms, 44,50–52
for demodicosis, 44,50,299, 311
tricholemmoma, 674, 675, 690
Trichophyton mentagrophytes, 29, 320, 321
clinical features,327, 328, 330
culture and identification,33, 34, 334–335
onychomycosis, 591
trichorrhexis nodosa, 61
tricyclic antidepressants, 181, 234
triethylphosphine goldseeauranofin
triiodothyronineseeT 3
trilostane, 815
for alopecia X, 341
for hyperadrenocorticism, 401–402, 411–412
trimeprazine, 816
trimethoprim + sulfadiazine, 816
for eosinophilic granuloma complex, 354
for nocardiosis, 538
for otitis, 550
trimethoprim + sulfamethoxazole,219,281, 816
tripelennamine citrate, 816
trizEDTA, 151
TSHseethyrotropin
tuberculosis, 510
client education and prognosis, 516
clinical features, 512
diagnostics, 513–514
signalment/history, 511
treatment, 515
zoonotic potential, 517
tumors, 13, 22
fine-needle aspiration, 46–47
skin and adnexaseeskin and adnexal tumors
see alsoneoplasia
Tylanseetylosin
Tylocineseetylosin
tylosin, 817
tympanum, 542,551–552
assessing patency, 545, 561
fluid accumulation behind, 544,554–555
rupture, 544, 556
sample collection through, 31, 35
tyrosine kinase inhibitors, 499
Tzanck preparation, 46
ulcer, 14, 25
biopsy technique, 37
cytology, 46
indolent (rodent)seeindolent ulcer
ulcerative dermatosis, 63–65
of collies and shelties, 64
leishmaniasis, 460, 464
linear feline, 64
Ultramseetramadol
ultrasonography
for hyperadrenocorticism, 397, 399, 411
for hypothyroidism, 420
for paraneoplastic dermatoses, 621
for superficial necrolytic dermatitis, 667, 671
ultraviolet light (UVL)-induced dermatoses, 574–578,
615, 672
urine cortisol-creatinine ratio, 398–399, 410
urticaria
adverse food reactions, 288, 294
atopic disease, 176, 182
drug-induced, 273, 281
hymenoptera stings, 243
mast cell tumors, 500
urticaria pigmentosa, 495, 496, 508
uveodermatologic syndrome, canine, 692–694
clinical features, 692–693,695–697
depigmentation, 65, 129
nasal planum, 67, 139vaccine reactions, cutaneous adverse, 273, 280
ischemic dermatopathy, 699, 700, 709
panniculitis, 570
patchy alopecia, 59, 71
vaccines, for pyoderma, 217
vacuolar degeneration, 40
Valiumseediazepam
Vancocinseevancomycin
Vancoledseevancomycin
vancomycin, 152, 817
vasculitis, 698–702
clinical features, 63,113,699–700,703–709
diagnostics, 700–701, 710
differential diagnosis, 274, 700
drug-induced hypersensitivity, 274, 275
leukocytoclastic, 698
signalment/history, 698–699
therapeutics, 701–702
vasoproliferative plaque, 576, 583
VDC-1101, 370
vesicles, 13,18, 37
vesicular cutaneous lupus erythematosus
(VCLE), 468, 470, 471
vestibular (cranial nerve VIII) deficits, 544, 548, 557
Vetalarseeketamine
Vetalogseetriamcinolone
Vetergesicseebuprenorphine hydrochloride
Vetorylseetrilostane
Vibramycinseedoxycycline
vidarabine, 715
video-otoscopy, 546, 562
vinblastine, 369, 498, 499
vincristine-cyclophosphamide-prednisolone
(COP), 369
vinegar (acetic acid) solutions,485, 548
viral dermatoses, 711–715
clawfold region, 66, 602
clinical features, 713
diagnostics, 714–715
differential diagnosis, 714
nasal planum, 67, 141
signalment/history, 711–713